The chart above plots the price of MEDP over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 38 sessions over that window: $432.69 on 22 May 2026 through $538 on 17 July 2026.
Market cap$15.0B
P/E (TTM)34.7
52-week range$312 – $630
Avg volume77.0K
Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 20, 2026
MEDP insider trades
SEC Form 4 · last 90 days · newest reported trade 13 Aug 2026
Open-market buys0
Open-market sells10
Net sold$38.46M
Non-trade filings5
DateInsiderTypeSharesValue
13 Aug 2026Troendle August J.President & CEOSell458$275K
12 Aug 2026Troendle August J.President & CEOSell11,366$6.84M
11 Aug 2026Troendle August J.President & CEOSell17,610$10.66M
11 Aug 2026McCarthy Cornelius P. IIIDirectorSell1,140$690K
10 Aug 2026Troendle August J.President & CEOSell5,534$3.33M
07 Aug 2026McCarthy Cornelius P. IIIDirectorSell795$465K
28 Jul 2026BURWIG SUSAN EExec. VP, OperationsSell7,500$4.50M
28 Jul 2026Troendle August J.President & CEOSell3,510$2.11M
27 Jul 2026Troendle August J.President & CEOSell3,728$2.24M
28 May 2026EWALD STEPHEN PGeneral Counsel & Corp. Secy.Sell16,349$7.36M
Compensation mechanics
Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.
DateInsiderTypeSharesValue
07 Aug 2026McCarthy Cornelius P. IIIDirectorOption exercise3,858$325K
30 Jun 2026Carley Brian TDirectorOption exercise36
30 Jun 2026Kraft Robert O.DirectorOption exercise33
30 Jun 2026McCarthy Cornelius P. IIIDirectorOption exercise28
28 May 2026EWALD STEPHEN PGeneral Counsel & Corp. Secy.Option exercise16,349$2.27M
MEDP reported financials
SEC EDGAR XBRL
MEDP reported revenue of $2.5B for the fiscal year ended 31 Dec 2025. Net income over the same period was $451.1M.
FigureReportedPeriod
Revenue
$2.5B
31 Dec 2025 fiscal year
Net income
$451.1M
31 Dec 2025 fiscal year
Diluted EPS
$15.28
31 Dec 2025 fiscal year
Total assets
$2.1B
30 Jun 2026 at period end
Total equity
$433.9M
30 Jun 2026 at period end
Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
MEDP earnings
SEC EDGAR
DatePeriodEPSRevenue
30 Jun 2026Q2 2026$4.25—
31 Mar 2026Q1 2026$4.28—
31 Dec 2025FY 2025$15.28—
30 Sep 2025Q3 2025$3.86—
30 Jun 2025Q2 2025$3.10—
31 Mar 2025Q1 2025$3.67—
31 Dec 2024FY 2024$12.63—
30 Sep 2024Q3 2024$3.01—
Next report no date announced in SEC filings yet
Reported figures & scheduled dates · SEC EDGAR filings
MEDP institutional holders
SEC Form 13F
9 of the 45 institutional funds we track reported a MEDP position for the quarter ended 30 Jun 2026 — a combined $1.2B; the latest of those filings landed 14 Aug 2026.